Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese Prefectures Struggle To Meet New Goals Of Flu Drug Stockpiles

This article was originally published in PharmAsia News

Executive Summary

Nearly a third of Japan's 47 prefectures have increased their stock of Roche's Tamiflu (oseltamivir) and GlaxoSmithKline's Relenza (zanamivir) to treat H1N1 flu cases should they occur. The 15 are stepping up their stockpiling of the drugs to meet a national government target of being able to treat as much as 45 percent of the population. A survey shows the stockpiling success varies widely by prefecture, with some nearly complete and others still struggling. The Japanese system calls for the central government to obtain half the drugs and each prefecture to acquire the other half. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071805

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel